Achilles Therapeutics plc - ADR logo

Achilles Therapeutics plc - ADR (ACHL)

Delisted
24 Mar 2025
NASDAQ (CM) NASDAQ (CM)
$
1. 48
0
0%
$
45.69M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 1.48
Previous Close
Investors:
Day Range
1.48 1.48
Year Range
0.63 1.51
Want to track ACHL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Achilles Therapeutics plc - ADR logo
ACHL Achilles Therapeutics plc - ADR
11 Nov 2024
-
-
Achilles Therapeutics plc - ADR logo
ACHL Achilles Therapeutics plc - ADR
26 Aug 2024
-
-
Achilles Therapeutics plc - ADR logo
ACHL Achilles Therapeutics plc - ADR
2 Aug 2024
-
-
Achilles Therapeutics plc - ADR logo
ACHL Achilles Therapeutics plc - ADR
8 May 2024
-
-
Achilles Therapeutics plc - ADR logo
ACHL Achilles Therapeutics plc - ADR
27 Mar 2024
-
-
Achilles Therapeutics plc - ADR logo
ACHL Achilles Therapeutics plc - ADR
5 Mar 2024
-
-
Achilles Therapeutics plc - ADR logo
ACHL Achilles Therapeutics plc - ADR
6 Nov 2023
-
-